Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Fabre-Kramer Pharmaceuticals Inc.
DescriptionAntidepressant agonist of serotonin (5-HT2) receptor and serotonin (5-HT1A) receptor
Molecular Target Serotonin (5-HT1A) receptor ; Serotonin (5-HT2) receptor
Mechanism of ActionSerotonin (5-HT1A) receptor agonist
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationDepression
Indication DetailsTreat depression
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today